| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |